Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Adaptive Biotechnologies Corp (ADPT)  
$3.96 0.16 (4.21%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 144,770,000
Market Cap: 573.29(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.335 - $8.78
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Adaptive Biotechnologies is a commercial-stage company developing the field of immune medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Co.'s immune medicine platform applies its main technologies to read the genetic code of a patient's immune system. Co.'s clinical diagnostic product, clonoSEQ, is authorized by the Food and Drug Administration for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia and chronic lymphocytic leukemia and is also available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 181,388 181,647 370,810 539,321
Total Sell Value $624,469 $625,539 $2,103,520 $3,574,731
Total People Sold 8 8 9 11
Total Sell Transactions 8 9 13 36
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 867
  Page 8 of 35  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Palaniappan Jyoti SVP, Diagnostics, T-Detect   •       –      –    2021-07-19 4 OE $22.55 $14,680 D/D 651 9,809     -
   Burris Michelle Director   –       •      –    2021-07-14 4 AS $36.80 $92,000 D/D (2,500) 1,504 -16%     
   Burris Michelle Director   –       •      –    2021-07-14 4 OE $7.80 $19,500 D/D 2,500 4,004     -
   Robins Chad M CEO and Chairman   •       •      –    2021-07-12 4 AS $38.24 $57,398 D/D (1,501) 1,716,960 -14%     
   Adams R Mark Chief Operating Officer   •       –      –    2021-07-08 4 AS $36.30 $81,820 D/D (2,254) 54,979 -12%     
   Adams R Mark Chief Operating Officer   •       –      –    2021-07-07 4 AS $39.42 $34,335 D/D (871) 57,233 -10%     
   Cohen Chad M Chief Financial Officer   •       –      –    2021-07-07 4 AS $38.17 $385,319 D/D (10,000) 21,604 -10%     
   Cohen Chad M Chief Financial Officer   •       –      –    2021-07-07 4 OE $6.55 $65,500 D/D 10,000 31,604     -
   Cohen Chad M Chief Financial Officer   •       –      –    2021-07-06 4 AS $38.83 $388,300 D/D (10,000) 21,604 -15%     
   Cohen Chad M Chief Financial Officer   •       –      –    2021-07-06 4 OE $6.55 $65,500 D/D 10,000 31,604     -
   Taylor Stacy L SVP and General Counsel   •       –      –    2021-06-30 4 AS $41.35 $172,614 D/D (4,167) 15,036 -10%     
   Taylor Stacy L SVP and General Counsel   •       –      –    2021-06-30 4 OE $6.55 $62,663 D/D 4,167 19,203     -
   Palaniappan Jyoti SVP, Diagnostics, T-Detect   •       –      –    2021-06-18 4 AS $39.80 $51,780 D/D (1,301) 9,158 -14%     
   Palaniappan Jyoti SVP, Diagnostics, T-Detect   •       –      –    2021-06-18 4 OE $22.55 $29,338 D/D 1,301 10,459     -
   Palaniappan Jyoti SVP, Diagnostics, T-Detect   •       –      –    2021-06-17 4 AS $40.00 $26,040 D/D (651) 9,158 -15%     
   Palaniappan Jyoti SVP, Diagnostics, T-Detect   •       –      –    2021-06-17 4 OE $22.55 $14,680 D/D 651 9,809     -
   Adams R Mark Chief Operating Officer   •       –      –    2021-06-17 4 AS $40.00 $583,320 D/D (14,583) 58,104 -15%     
   Adams R Mark Chief Operating Officer   •       –      –    2021-06-17 4 OE $28.10 $409,782 D/D 14,583 72,687     -
   Taylor Stacy L SVP and General Counsel   •       –      –    2021-06-17 4 AS $40.00 $166,640 D/D (4,166) 15,036 -15%     
   Taylor Stacy L SVP and General Counsel   •       –      –    2021-06-17 4 OE $6.55 $62,655 D/D 4,166 19,202     -
   Burris Michelle Director   –       •      –    2021-06-17 4 AS $40.00 $160,000 D/D (4,000) 1,504 -15%     
   Burris Michelle Director   –       •      –    2021-06-17 4 OE $7.80 $31,200 D/D 4,000 5,504     -
   Robins Chad M CEO and Chairman   •       •      –    2021-06-17 4 AS $38.55 $207,729 D/D (5,255) 1,718,461 -15%     
   Robins Chad M CEO and Chairman   •       •      –    2021-06-16 4 AS $38.13 $180,927 D/D (4,745) 1,723,716 -11%     
   Robins Chad M CEO and Chairman   •       •      –    2021-06-15 4 AS $38.22 $765,309 D/D (20,000) 1,728,461 -12%     
  867 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 35
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us